Attention A T users. To access the menus on this page please perform the following steps.
1. Please switch auto forms mode to off.
2. Hit enter to expand a main menu option (Health, Benefits, etc).
3. To enter and activate the submenu links, hit the down arrow.
You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.
Study Chair: Scott L. Hummel, MD, MS – Ann Arbor VA Medical Center For further information, please email: scott.hummel@va.gov
CSP 2026 Title: Beta Blocker Dialyzability on Cardiovascular Outcomes (BRAVO): Metoprolol Succinate vs Carvedilol for prevention of adverse cardiovascular outcomes in hemodialysis patients
Coordinating Center: Boston
Study Chairs:
Areef Ishani, MD, MS - Minneapolis VA Medical Center
James Kaufman, MD – New York Harbor VA Medical Center